New combination therapy could help fight difficult-to-treat cancers with common mutations

Scientists describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving proteins in a death grip. This combination of two small molecules has the potential to treat not only BRAF mutated melanoma but also additional aggressive subtypes of cancers, including melanoma, lung, pancreatic and colon cancers that harbor common mutations in cancer genes called RAS or NF1.
Read Original Article: New combination therapy could help fight difficult-to-treat cancers with common mutations »